{"schema_version":"secwatch.filing_event.v1","accession":"0001729149-26-000008","form_type":"8-K","ticker":"VMD","cik":"0001729149","company_name":"VIEMED HEALTHCARE, INC.","filed_at":"2026-03-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.020566+00:00","generated_at":"2026-05-15T21:44:24.239828+00:00","sec_items":["2.02","7.01","8.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Viemed posts record FY2025 revenue $270.3M; net income +33%; guides FY2026 rev $310-320M","bullets":["Q4 revenue $76.2M (record, +26% YoY); FY revenue $270.3M (record, +21% YoY).","FY2025 net income $14.9M ($0.37 diluted EPS), +33% YoY; adjusted EBITDA record $61.4M.","FY2025 operating cash flow $51.9M; free cash flow $28.1M (more than doubled YoY).","2026 guidance: revenue $310-320M, adjusted EBITDA $65-69M, capex 10-11.5% of revenue.","Board authorized share repurchase of up to 1,930,131 shares (~5% outstanding) through March 2027."],"urls":{"canonical":"https://secwatch.observer/filing/0001729149-26-000008","json":"https://secwatch.observer/filing/0001729149-26-000008.json","markdown":"https://secwatch.observer/filing/0001729149-26-000008.md","text":"https://secwatch.observer/filing/0001729149-26-000008.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1729149/000172914926000008/0001729149-26-000008-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1729149/000172914926000008/vmd-20260304.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T21:44:24.239828+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}